WashU announces new academic-industry collaboration with Bristol Myers Squibb
Multiyear program will provide hands-on training at the pharmaceutical company, fund translational neuroscience research at WashU
Colditz, Jiang receive Chancellor’s Award for Innovation and Entrepreneurship
WashU Medicine researchers developed AI tool that refines breast-cancer risk prediction
WashU in top 10 universities for translating discoveries into real-world solutions
New Cure Innovation Index cites strengths in research, institutional support for commercializing biomedical advances made in WashU labs
Bateman and Holtzman receive 2026 American Innovator Award
WashU Medicine neurologists honored for blood-based Alzheimer’s diagnostic test
Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway
Levy appointed executive vice chancellor for medical affairs, dean of WashU Medicine
Bruce D. Levy, MD, is an accomplished physician-scientist and a highly regarded leader in academic medicine
WashU’s economic impact totals $9.8 billion
University drew $1 billion in external funding that led to scientific advances, new jobs
WashU startups attract record-setting $1.7 billion in private-sector investment over past year
Capital accelerates commercialization of WashU discoveries into life-changing diagnostics, therapeutics and medical devices